# Editorial: Advancing antibiotic candidates for eradication of persistent bacterial infections

**Authors:** Laurent A. Bekale, Jessica Amber Jennings, Xilin Zhao

PMC · DOI: 10.3389/fphar.2026.1801789 · Frontiers in Pharmacology · 2026-02-23

## Full-text entities

- **Diseases:** infection (MESH:D007239), TB (MESH:D014390), Bacterial Infections (MESH:D001424)
- **Chemicals:** ethambutol (MESH:D004977), macrolides (MESH:D018942), rifampicin (MESH:D012293), acetate (MESH:D000085), Glucose (MESH:D005947), ATP (MESH:D000255), carbon (MESH:D002244), gold (MESH:D006046), Clarithromycin (MESH:D017291), doxycycline (MESH:D004318), oxygen (MESH:D010100), isoniazid (MESH:D007538), 13C (MESH:C000615229)
- **Species:** Mycobacterium tuberculosis (species) [taxon 1773], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606], Prescottella equi (species) [taxon 43767], Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968204/full.md

---
Source: https://tomesphere.com/paper/PMC12968204